. Expression of the 5 long non-coding RNAs in tumor and non-tumor tissues. Differential expression of (A) PRKG1-AS1, (B) ITGB1-DT, (C) NPSR1-AS1, (D) LMO7DN and (E) OGFRP1 between tumor and non-tumor tissues. The P-value are derived from the differential expression analysis, and P<0.05 was considered to indicate a statistically significant difference. *** P<0.001 vs. non-tumor tissues. OGFRP1, opioid growth factor receptor pseudogene 1; ITGB1-DT, integrin subunit beta 1 divergent transcript; LMO7DN, LIM domain 7 downstream neighbor; NPSR1-AS1, neuropeptide S receptor 1-antisense RNA 1; PRKG1-AS1, protein kinase cyclic GMP-dependent 1-antisense RNA 1.
. Results of the analysis of differentially expressed mRNAs using the same data and methods as for long non-coding RNA. (A) Forest Plot of the 5-mRNA signature. (B) Kaplan-Meier survival curves for high-and low-risk groups, and the '+' on the survival curves represents the censored data-points. (C) ROC curve of the 5-mRNA signature in predicting the 5-year survival rate. ROC, receiver operating characteristic; AUC, area under ROC curve; FAM189A2, family with sequence similarity 189 member A2; C1QTNF6, C1q and tumor necrosis factor related 6; COL22A1, collagen type XXII alpha 1 chain; NTSR1, neurotensin receptor 1; CIDEC, cell death inducing DNA fragmentation factor subunit alpha like effector c. Figure S3 . Results of the analysis of the differentially expressed long non-coding RNAs and mRNAs using the same data and methods as above. (A) Forest Plot of the 4-gene signature. (B) Kaplan-Meier survival curves for high-and low-risk groups, and the '+' on the survival curves represents the censored data-points. (C) ROC curve of the 4-gene signature in predicting the 5-year survival rate. COL22A1, collagen type XXII alpha 1 chain; NTSR1, neurotensin receptor 1; OGFRP1, opioid growth factor receptor pseudogene 1; LINC01322, long intergenic non-protein coding RNA 1322; ROC, receiver operating characteristic; AUC, area under ROC curve. 
Gene
Forward sequence (5'-3') Reverse sequence (5'-3')   PRKG1-AS1  CTACCAGCGAGCGTTATAGCAGAC  TGCACAGTCAGCGAGTATTGGC  ITGB1-DT  CCATTAGGAAGACGGTGCAGTGTG  GTGCCTCCTCCACCACCTACTC  NPSR1-AS1  GGAGTTCAAGTCCAACCTGGCAAC  ACTCTGGCTCTAGTGCAGTGGTG  LMO7DN  TGTATCTGGTGGAGGAGGCTTGG  TCGGTTGTGACAATGAGGACTGT  OGFRP1 GCGTGGATTGATTGAGGAGACTGG GCTGGCAAGTGAGGAAGGACATC
